STALEY CAPITAL ADVISERS’s VYNE Therapeutics VYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $84.9K | Hold |
51,472
| – | – | ﹤0.01% | 189 |
|
|
2025
Q1 | $81.3K | Buy |
51,472
+15,000
| +41% | +$23.7K | ﹤0.01% | 185 |
|
|
2024
Q4 | $122K | Hold |
36,472
| – | – | 0.01% | 173 |
|
|
2024
Q3 | $68.6K | Hold |
36,472
| – | – | ﹤0.01% | 180 |
|
|
2024
Q2 | $71.9K | Hold |
36,472
| – | – | ﹤0.01% | 177 |
|
|
2024
Q1 | $112K | Hold |
36,472
| – | – | 0.01% | 177 |
|
|
2023
Q4 | $85K | Buy |
36,472
+13,000
| +55% | +$30.3K | ﹤0.01% | 176 |
|
|
2023
Q3 | $94.8K | Hold |
23,472
| – | – | 0.01% | 171 |
|
|
2023
Q2 | $96.2K | Hold |
23,472
| – | – | 0.01% | 180 |
|
|
2023
Q1 | $72K | Buy |
23,472
+20,000
| +576% | +$61.4K | ﹤0.01% | 174 |
|
|
2022
Q4 | $9K | Hold |
3,472
| – | – | ﹤0.01% | 166 |
|
|
2022
Q3 | $14K | Hold |
3,472
| – | – | ﹤0.01% | 167 |
|
|
2022
Q2 | $24K | Hold |
3,472
| – | – | ﹤0.01% | 167 |
|
|
2022
Q1 | $41K | Hold |
3,472
| – | – | ﹤0.01% | 178 |
|
|
2021
Q4 | $64K | Buy |
3,472
+694
| +25% | +$12.8K | ﹤0.01% | 187 |
|
|
2021
Q3 | $70K | Buy |
2,778
+695
| +33% | +$17.5K | ﹤0.01% | 180 |
|
|
2021
Q2 | $132K | Buy |
2,083
+694
| +50% | +$44K | 0.01% | 177 |
|
|
2021
Q1 | $171K | Buy |
1,389
+695
| +100% | +$85.6K | 0.01% | 178 |
|
|
2020
Q4 | $79K | Buy |
+694
| New | +$79K | ﹤0.01% | 178 |
|